Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ocuphire Pharma Inc shares valued at $21,000 were purchased by Jhaveri Nirav S. on Mar 21 ’24. At $2.10 per share, Jhaveri Nirav S. acquired 10,000 shares. The insider’s holdings grew to 150,000 shares worth approximately $0.28 million following the completion of this transaction.
Also, SCHACHLE JOSEPH K purchased 2,000 shares, netting a total of over 4,100 in proceeds. Following the buying of shares at $2.05 each, the insider now holds 2,000 shares.
Before that, Magrath George had added 25,000 shares to its account. In a trade valued at $49,050, the Chief Executive Officer bought Ocuphire Pharma Inc shares for $1.96 each. Upon closing the transaction, the insider’s holdings increased to 25,000 shares, worth approximately $0.79 million.
Analyzing OCUP Stock Performance
During the last five days, there has been a surge of approximately 20.52%. Over the course of the year, Ocuphire Pharma Inc shares have dropped approximately -38.54%. Shares of the company reached a 52-week high of $3.3994 on 01/10/24 and a 52-week low of $1.5000 on 04/25/24. A 50-day SMA is recorded $1.9976, while a 200-day SMA reached $2.9556. Nevertheless, trading volume fell to 0.66 million shares from 45200.0 shares the previous day.
Support And Resistance Levels for Ocuphire Pharma Inc (OCUP)
According to the 24-hour chart, there is a support level at 1.6700, which, if violated, would cause prices to drop to 1.4900. In the upper region, resistance lies at 2.0100. The next price resistance is at 2.1700. RSI (Relative Strength Index) is 53.79 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0477, which suggests the price will decrease in the coming days. Percent R is at 28.57%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
